The frequent lack of fibrin at the plaque surface in carotid endarterectomy specimens suggests potential inherent limitations of standard medical treatment for carotid artery disease.
Answers are grounded in this paper and cite their sources.
May suggest limitations of standard medical therapy in carotid disease; hypothesis-generating and requires prospective validation.
We evaluated 40 consecutive carotid endarterectomy specimens for the presence of fibrin. Intraplaque hemorrhage was noted in 93% of specimens. At the plaque surface, there were two patterns of fibrin distribution. Type I, suggesting a lumen thrombus, was found in 7 specimens. Type II, suggesting an intraplaque hemorrhage at the lumen surface, was found in 15 specimens. These changes were not significantly associated with the presence of ischemic symptoms or the use of antiplatelet or anticoagulant medications. All specimens with Type I change had arteriographic evidence of at least 70% diameter stenosis. The frequent lack of fibrin at the plaque surface suggests that there may be inherent limitations of standard medical treatment for carotid artery disease.
No takes yet. Share an insight, caveat, or question.
Fisher et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: